Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CD94/NKG2A-Qa-1b Axis as a Key Modulator of Vaccine Responsiveness in Aging Populations

ABSTRACT: Vaccine responses decline with age, yet underlying mechanisms remain unclear. Using an Alum-adjuvanted spike (S+Alum) vaccine, this study identifies an aging-linked pathway in which senescence-associated secretory phenotype cytokines (CCL2, IL-6, IFN-γ) at the injection site are upregulated and associate with increased H2-T23 (Qa-1b) expression on monocytes. These H2-T23high monocytes interact with MHCIIhigh cDC2 via IL-10/TGF-β, limiting dendritic-cell antigen presentation, and engage the CD94/NKG2A-Qa-1b checkpoint on T cells, further dampening immunity. In humans, HLA-E+ monocytes and NKG2A⁺ T cells are infrequent in young individuals but show higher prevalence in peripheral blood from older adults, highlighting this pathway as a regulatory target. Blocking the CD94/NKG2A-Qa-1b axis thus emerges as a potential strategy to enhance vaccine performance in aging populations. Overall, the findings define a mechanistic link between SASP-driven myeloid programming, impaired antigen presentation, and checkpoint-mediated T-cell restraint in aging, with implications for vaccine design tailored to older individuals.

ORGANISM(S): Mus musculus

PROVIDER: GSE309190 | GEO | 2025/09/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

CD94/NKG2A-Qa-1b Axis as a Key Modulator of Vaccine Responsiveness in Aging Populations

Project description:CD94/NKG2A-Qa-1b Axis as a Key Modulator of Vaccine Responsiveness in Aging Populations

| PRJNA1334303 | ENA

Targeting ERAP enhances anti-tumor immunity by disrupting the NKG2A/HLA-E inhibitory checkpoint

Project description:New targets that enhance anti-tumor immunity must be identified to improve the efficacy of cancer immunotherapy. Here we show that loss of endoplasmic reticulum aminopeptidase (ERAP) family proteins improves anti-tumor immunity and synergizes with immune checkpoint blockade. Mechanistically, we show that loss of ERAP inactivates the HLA-E/NKG2A checkpoint, which normally restrains tumor killing by both CD8+ T cells and NK cells. The inhibitory activity of HLA-E is dependent on its presentation of a restricted set of invariant epitopes which form the binding surface for the NKG2A/CD94 receptor complex. Using genetic screening, in vivo models, cell-based assays, and immunopeptidomics, we show that loss of ERAP activity prevents the processing of these invariant peptides and alters the presented peptidome of both HLA-E and classical MHC-I. HLA-E neo-peptides presented after ERAP deletion are unable to bind the NKG2A/CD94 receptor, rendering tumor cells highly susceptible to killing by NKG2A+ cytotoxic T and NK cells. Thus, loss of ERAP phenocopies the loss or inhibition of the HLA-E/NKG2A pathway and represents an attractive therapeutic approach to inhibit this critical checkpoint. More broadly, this work identifies ERAP1/2 as druggable intracellular enzymes that could be targeted using small molecules to inactivate a cell-surface inhibitory pathway and represents a novel approach to therapeutic modulation of immune responses.

2024-11-21 | PXD052031 | Pride

ATAC-seq profiling in CD14+ cells isolated from rhesus macaques vaccinated with V1-deleted DNA/ALVAC/gp120 vaccine [study 2]

Project description:We analyzed innate and adaptive immune responses elicited by the V1-deleted DNA/ALVAC/gp120/alum vaccine in non-human primates. Following SIVmac251 challenge exposure, we observed reduced risk of SIV acquisition comparing vaccinated animals to controls, confirming th ability of this vaccine strategy in decreasing the risk of SIV acquisition against vaginal exposure. Transcriptome and chromatin accessibility in CD14+ cells were analyzed by RNA-seq and ATAC-seq. Epigenetic reprogramming in CD14+ cells of the cyclic AMP/CREB pathway correlated with vaccine efficacy. The efficacy of V1-delted DNA/ALVAC/gp120/alum vaccine, based on V2-specific antibodies mediating apoptosis of infected cells (V2-ADCC), is complemented by efferocytosis, a cyclic AMP (cAMP)-dependent antiphlogistic engulfment of apoptotic cells by CD14+ monocytes. Our data support the protective role for CREB1 expression in monocytes and posit that efferocytosis, through the prompt and effective removal of apoptotic infected cells, contributes to vaccine efficacy by decreasing inflammation and maintaining tissue homeostasis.

2023-01-06 | GSE188879 | GEO

RNA-seq profiling in CD14+ cells isolated from rhesus macaques vaccinated with V1-deleted DNA/ALVAC/gp120 vaccine

2023-01-06 | GSE189032 | GEO

Production of MHCII-expressing classical monocytes increases during aging in mice and humans

Project description:Aging is associated with increased monocyte production and altered monocyte function. Classical monocytes are heterogenous and a shift in their subset composition may underlie some of their apparent functional changes during aging. We have previously shown that mouse granulocyte-monocyte progenitors (GMPs) produce “neutrophil-like” monocytes (NeuMo), whereas monocyte-dendritic cell progenitors (MDPs) produce monocyte-derived dendritic cell (moDC)-producing monocytes (DCMo). Here, we demonstrate that classical monocytes from the bone marrow of old male and female mice have higher expression of DCMo signature genes (H2-Aa, H2-Ab1, H2-Eb1, Cd74), and that more classical monocytes express MHCII and CD74 protein. Moreover, we show that bone marrow MDPs and classical monocytes from old mice yield more moDC. We also demonstrate higher expression of Aw112010 in old monocytes and that Aw112010 lncRNA activity regulates MHCII induction in macrophages, which suggests that elevated Aw112010 levels may underlie increased MHCII expression during monocyte aging. Finally, we show that classical monocyte expression of MHCII is also elevated during healthy aging in humans. Thus, aging-associated changes in monocyte production may underlie altered monocyte function and have implications for aging-associated disorders.

2022-08-30 | GSE207063 | GEO

Single-cell RNA sequencing reveals the transcriptional landscape and heterogeneity of macrophages in intestinal tissue of WT and CD163+ macrophage-deficient mice.

Project description:CD163 macrophages, which markedly accumulated in inflammation and tumor tissues possessed markedly immunosuppressive functions on immune cells, especially effective cells such as CD8 cells. However, the mechanism of CD163 macrophages in regulating immune responses remains to be illusive. Using single cell-sequence techniques, we identified CD163 macrophage subset in the colon tissues. Meanwhile, we also characterized CD163 macrophage associated immune cell populations and subpopulations in mouse colon tissues. We found that CD163+ macrophage subset in the colon was related to gut microbiota. Deletion of CD163+ macrophage subset could markedly increase the proportions of the immune cell subsets such as CD8 and NK cells. Mechanistically, gut microbiota mediated CD163+ macrophage subpopulations can down-regulate CD8 and NK cells through inhibitory molecules CD94/NKG2a (Kird1/Kirc1 in mice) and their ligand HLA-E /QA-1 (Human/mice) on the surface of CD163+ macrophages.

2025-02-14 | GSE289171 | GEO

Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells

Project description:A key mechanism of tumor resistance to immune cells is mediated by expression of peptide-loaded HLA-E in tumor cells, which suppresses natural killer (NK) cell activity via ligation of the NK inhibitory receptor CD94/NKG2A. To bypass HLA-E inhibition, we developed a way to generate highly functional NK cells lacking NKG2A. Constructs containing a single-chain variable fragment derived from an anti-NKG2A antibody were linked to endoplasmic reticulum-retention domains. After retroviral transduction in human peripheral blood NK cells, these NKG2A Protein Expression Blockers (PEBLs) abrogated NKG2A expression. The resulting NKG2Anull NK cells had higher cytotoxicity against HLA-E-expressing tumor cells.

2019-05-17 | GSE127081 | GEO

LAG-3 sustains TOX and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity

Project description:Exhausted CD8 T cells (Tex) found in chronic viral infection and cancer are defined by sustained co-expression of inhibitory receptors (IRs). Tex can be reinvigorated by blocking IRs, such as PD-1, but synergistic reinvigoration of Tex and enhanced disease control can be achieved by co-targeting multiple IRs including co-blockade of PD-1 and LAG-3, a treatment recently FDA-approved for melanoma. Despite the promise of anti-PD-1/anti-LAG-3 therapy, the cellular and molecular changes intrinsic to CD8 T cells when one or more of these IR pathways are disrupted remain poorly understood. To dissect these IR pathways and their interactions with each other, we used a quadruple co-transfer model to investigate the impact of singular or combined loss of PD-1 and LAG-3 on the differentiation of Tex during chronic viral infection. These analyses revealed distinct roles of PD-1 and LAG-3 in regulating Tex proliferation and cytokine/cytotoxic functions, respectively. Moreover, these studies identified key roles for LAG-3 that complement PD-1 biology including an essential role for LAG-3 in sustaining TOX expression and associated Tex durability. Finally, these studies uncovered a LAG-3-dependent circuit for the generation of an effector-like CD94/NKG2+ subset of Tex capable of enhanced cytotoxicity mediated by recognition of the stress-induced ligand Qa-1b with similar regulation of CD94/NKG2 family members in humans with combination anti-PD-1/anti-LAG-3. These analyses identify a role for LAG-3 in governing CD8 T cell Qa-1b-restricted immune sensing and surveillance. Together, these results disentangled the underlying non-redundant mechanisms of PD-1 and LAG-3 and their synergy in regulating Tex revealing additional immunotherapeutic opportunities based on these pathways.

2025-03-01 | GSE271184 | GEO

CD163 macrophages suppress CD8 and NK cells through CD163 mediated HLA-E (H2-T23)

Project description:CD163 macrophages, which can be identified in different tissues of individuals such as the colon and tumor tissues, possessed markedly immunosuppressive functions on immune cells, especially effective cells such as CD8 cells. However, the mechanism(s) by which CD163 macrophages inhibit immune responses remains to be illusive. Using single cell-sequence techniques, we identified CD163+ macrophage subset in the colon tissues. Meanwhile, we also characterized CD163+ macrophage associated immune cell populations and subpopulations in mouse colon tissues. Deletion of CD163+ macrophage subset could markedly increase the proportions of CD8 and NK cells. Mechanistically, CD163+ macrophage subpopulations can inhibit the proliferation of CD8 and NK cells through inhibitory molecules CD94/NKG2a (KLRD1/KLRC1 in mice) and their ligand HLA-E /H2-T23 (Human/mice) on the surface of CD163+ macrophages. Importantly, CD163 in macrophages could promote the expression of HLA-E/H2-T23 expression through inducing the expression of signal peptide peptidase (SPP), offering a target for immunotherapy in CD8 and NK cells associated immunosuppressive diseases such as tumor. Taken together, we demonstrate that CD163+macrophage subpopulation plays a critical role in suppressing CD8 and NK cells through CD163 mediated HLA-E/H2-T23.

2025-03-20 | GSE292042 | GEO

Transcriptomic profiling of rhesus macaques vaccinated with ALVAC-SIV/gp120 adjuvanted in Alum or MF59.

Project description:The Canarypox/gp120/Alum vaccines decreased the risk of HIV acquisition in humans. We demonstrate here the efficacy of this vaccine regimen also in the SIVmac251 macaque model when we used the alum but not the MF59 adjuvant. Analysis of innate and adaptive cell responses, envelope antibodies Fc profiles and glycoforms demonstrated a lower inflammatory response with alum than MF59. Alum elicited mucosal V2 peptide-specific IgG associated with vaccine efficacy whereas the MF59 induced mucosal V2 peptide-specific IgG associated with increased risk of infection. Alum modulated the expression of 12 genes, 7 of which are part of the RAS pathway, that correlates with vaccine efficacy and were linked to innate responses that preserve mucosal integrity and adaptive mucosal antibody response to V2. Thus, activation of the RAS pathway, preservation of mucosal integrity and mucosal antibody to V2 in concert, reduce the risk of SIVmac251 acquisition.

2016-05-29 | GSE72624 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data